Advertisement

Topics

BUHLMANN Laboratories AG Company Profile

12:09 EDT 26th September 2017 | BioPortfolio

BUHLMANN not only stands for outstanding and unique parameters. It also means 30 years of successful history as a medium sized, independent company near Basel.
BUHLMANN Laboratories AG has been founded in 1976 as a distribution company for immunodiagnostics. At that time, BUHLMANN was a “First Distributor” of a then still small company DPC (Diagnostics Products Corp., Los Angeles, USA) - today’s world leader in immunoassays. The excellent quality and some exclusive parameters of DPC led to a rapid and long lasting success in the Swiss and Austrian markets. In 1991, DPC and BUHLMANN successfully introduced Immulite, the first generation of automated immuno-analyzers. Today, with DPC, we are number four in the Swiss IVD market and number three in Austria.

Together with our partner DPC we offer the latest developments in terms of lab automation. With the recently launched Sample Management System (SMS) and new product lines, such as the first 3rd Generation Specific IgE test on the market, we enable labs to consolidate nearly 100 immunoassays and 380 allergens on one platform.

In 1979, BUHLMANN started developing and manufacturing innovative in vitro diagnostic kits by early identification of relevant new parameters. A variety of these niche products are still unique and remain unchallenged to date.

Location

Baselstrasse 55
Schönenbuch
4124
Switzerland


News Articles [348 Associated News Articles listed on BioPortfolio]

Eppendorf Implements Intuitive Programming of Liquid Handling Tasks

LabRoots will host the webinar September 6, where attendees will learn about general liquid handling tasks and receive an introduction to the Eppendorf line of epMotion automated liquid handling syste...

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Enterome to move its research laboratories

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology ...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will...

Wall Street analysts forecast that Impax Laboratories Inc will post $196.18 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Impax Laboratories'...

Analyzing Impax Laboratories

Pfizer and Impax Laboratories are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional owner...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

Zacks: Analysts Anticipate Impax Laboratories Inc (IPXL) to Announce $0.13 EPS

Equities analysts expect that Impax Laboratories Inc will post earnings per share of $0.13 for the current quarter, according to Zacks Investment Research . Four analysts have made estimates for Impax...

Morning Stock Stories: Impax Laboratories, Inc.

With a market cap of 1.21B, Impax Laboratories, Inc. has a large market cap size. Impax Laboratories, Inc. has been on the stock market since its IPO date on the 12/19/1995.

PubMed Articles [192 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

This Is not Participatory Design - A Critical Analysis of Eight Living Laboratories.

Design of Health Technology for elderly and care personnel has a high priority because of a severe increase of elderly citizens in need of health care combined with a decrease of resources in the heal...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on resul...

Clinical Trials [231 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [932 Associated Companies listed on BioPortfolio]

BUHLMANN Laboratories AG

BUHLMANN not only stands for outstanding and unique parameters. It also means 30 years of successful history as a medium sized, independent company near Basel. BUHLMANN Laboratories AG has been found...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

Rainbow Scientific, Inc.

Rainbow Scientific, Inc. markets, sells, and distributes state-of-the-art medical diagnostic test kits to both research and clinical laboratories. From our Windsor, Connecticut location, we are commit...

Bedford Laboratories

Bedford Laboratories supplies the U.S. and International markets with multisource and specialty injectable products offering a broad range of multisource injectables across multiple therapeutic classe...

Carma Laboratories Inc.

For more than 70 years, Milwaukee-based Carma Laboratories has manufactured Carmex brand lip balm. Carmex products are available at most U.S. retailers and online. For more information, contact Carma ...

More Information about "BUHLMANN Laboratories AG" on BioPortfolio

We have published hundreds of BUHLMANN Laboratories AG news stories on BioPortfolio along with dozens of BUHLMANN Laboratories AG Clinical Trials and PubMed Articles about BUHLMANN Laboratories AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BUHLMANN Laboratories AG Companies in our database. You can also find out about relevant BUHLMANN Laboratories AG Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record